Immunovant (IMVT) Cash from Operations (2019 - 2026)
Immunovant (IMVT) posted Cash from Operations of 95059000.0 for Q1 2026, down 2.96% on a QoQ basis from 92325000.0 in Q4 2025, and up 14.08% year-over-year from 83326407.98 in Q1 2025.
Immunovant (IMVT) Cash from Operations (2019 - 2026) Analysis & Trends
Immunovant's Cash from Operations history runs 8 years deep, the most recent figure standing at 95059000.0 for Q1 2026.
- Quarterly Cash from Operations rose 14.08% year-over-year to 95059000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 407310000.0 (down 8.36% YoY) and the FY2026 annual result came in at 407310000.0, down 8.36% from the prior year.
- Cash from Operations was 95059000.0 for Q1 2026 at Immunovant, down from 92325000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 20186000.0 in Q3 2022 and bottomed at 117411000.0 in Q2 2025.
- A 5-year average of 71680000.0 and a median of 65819000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 210.26% — and 2023, when it advanced 28.03%.
- Immunovant's Cash from Operations stood at 46395000.0 in 2022, then slipped by 1.52% to 47098000.0 in 2023, then tumbled by 113.15% to 100391000.0 in 2024, then increased by 8.03% to 92325000.0 in 2025, then retreated by 2.96% to 95059000.0 in 2026.
- Business Quant data shows IMVT's Cash from Operations at 95059000.0 in Q1 2026, 92325000.0 in Q4 2025, and 102515000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -95.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.06 Mn |
| Mar 31, 2026 | -95.06 Mn |
| Dec 31, 2025 | -92.33 Mn |
| Dec 31, 2025 | -92.33 Mn |
| Sep 30, 2025 | -102.52 Mn |
| Sep 30, 2025 | -102.52 Mn |
| Jun 30, 2025 | -117.41 Mn |
| Jun 30, 2025 | -117.41 Mn |
| Mar 31, 2025 | -110.64 Mn |
| Mar 31, 2025 | -110.64 Mn |
| Dec 31, 2024 | -100.39 Mn |
| Dec 31, 2024 | -100.39 Mn |
| Sep 30, 2024 | -88.65 Mn |
| Sep 30, 2024 | -88.65 Mn |
| Jun 30, 2024 | -76.20 Mn |
| Jun 30, 2024 | -76.20 Mn |
| Mar 31, 2024 | -59.70 Mn |
| Mar 31, 2024 | -59.70 Mn |
| Dec 31, 2023 | -47.10 Mn |
| Dec 31, 2023 | -47.10 Mn |